Goldman Sachs
DGX icon

Goldman Sachs’s Quest Diagnostics DGX Stock Holding History

Goldman Sachs’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-27,000
Closed -$4.69M – 6598
2025
Q4 		$4.69M Buy
+27,000
New +$4.92M ﹤0.01% 3810
2018
Q1 		– Sell
-1,200
Closed -$118K – 5977
2017
Q4 		$118K Sell
1,200
-8,600
-88% -$815K ﹤0.01% 5686
2017
Q3 		$918K Buy
9,800
+9,600
+4,800% +$1.02M ﹤0.01% 4647
2017
Q2 		$22K Sell
200
-700
-78% -$74K ﹤0.01% 6542
2017
Q1 		$88K Sell
900
-6,900
-88% -$658K ﹤0.01% 6106
2016
Q4 		$717K Sell
7,800
-5,800
-43% -$500K ﹤0.01% 4742
2016
Q3 		$1.15M Buy
13,600
+7,300
+116% +$613K ﹤0.01% 4280
2016
Q2 		$513K Buy
6,300
+200
+3% +$15.2K ﹤0.01% 4835
2016
Q1 		$436K Buy
6,100
+3,600
+144% +$241K ﹤0.01% 4879
2015
Q4 		$178K Sell
2,500
-2,400
-49% -$161K ﹤0.01% 5791
2015
Q3 		$301K Sell
4,900
-1,200
-20% -$83.9K ﹤0.01% 5602
2015
Q2 		$442K Sell
6,100
-600
-9% -$44.3K ﹤0.01% 5320
2015
Q1 		$515K Sell
6,700
-12,300
-65% -$881K ﹤0.01% 5096
2014
Q4 		$1.27M Sell
19,000
-33,800
-64% -$2.13M ﹤0.01% 4308
2014
Q3 		$3.2M Sell
52,800
-22,400
-30% -$1.38M ﹤0.01% 3459
2014
Q2 		$4.41M Sell
75,200
-576,800
-88% -$33.8M ﹤0.01% 3189
2014
Q1 		$37.8M Sell
652,000
-47,900
-7% -$2.57M 0.01% 1258
2013
Q4 		$37.5M Buy
699,900
+332,400
+90% +$19.7M 0.01% 1269
2013
Q3 		$22.7M Buy
367,500
+324,600
+757% +$19.4M 0.01% 1522
2013
Q2 		$2.6M Buy
+42,900
New +$2.56M ﹤0.01% 3446

Other funds holding DGX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
EIG
EdgePoint Investment Group Toronto, Ontario, Canada $12.5B AUM 31.7% 1-Year Est. Return

Goldman Sachs's DGX Position: Q1 2026 in Review

Goldman Sachs reduced its Quest Diagnostics (DGX) stake by 21% in Q1 2026, selling an estimated $70M and leaving 1,348,694 shares worth $264M. The position accounts for 0.03% of the portfolio, ranked #547.

Goldman Sachs first reported a position in DGX in Q2 2013 and has held it in 52 quarters since. The position peaked at $297M in Q4 2025. 1,063 funds tracked by Wall St. Rank hold DGX as of Q1 2026.

  • Goldman Sachs held 1,348,694 shares of Quest Diagnostics worth $264M as of Q1 2026.
  • Goldman Sachs sold 360,231 Quest Diagnostics shares in Q1 2026, an estimated $70M.
  • Quest Diagnostics made up 0.03% of Goldman Sachs's portfolio in Q1 2026, its #547 holding.
  • Goldman Sachs first reported a position in Quest Diagnostics in Q2 2013 and has held it in 52 quarters since.
  • Goldman Sachs's Quest Diagnostics position peaked at $297M in Q4 2025.
  • 1,063 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2026.

Based on Goldman Sachs's 13F filing for Q1 2026, filed 15 May 2026.